Editas Medicine

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EDIT and other ETFs, options, and stocks.

About EDIT

Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). 

CEO
Gilmore O’Neill
CEOGilmore O’Neill
Employees
246
Employees246
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2013
Founded2013
Employees
246
Employees246

EDIT Key Statistics

Market cap
129.75M
Market cap129.75M
Price-Earnings ratio
-0.54
Price-Earnings ratio-0.54
Dividend yield
—
Dividend yield—
Average volume
2.08M
Average volume2.08M
High today
$1.69
High today$1.69
Low today
$1.54
Low today$1.54
Open price
$1.63
Open price$1.63
Volume
2.11M
Volume2.11M
52 Week high
$6.69
52 Week high$6.69
52 Week low
$0.9101
52 Week low$0.9101

Analyst ratings

53%

of 15 ratings
Buy
33.3%
Hold
53.3%
Sell
13.3%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.